Core Points - Jiangxi Fushine Pharmaceutical Co., Ltd. aims to maximize shareholder value while providing safe and effective pharmaceutical products globally [3][4] - The company was established on August 29, 2012, and registered with a capital of RMB 538,648,934 [3][4] - The company operates as a public limited company and is governed by its articles of association, which are legally binding [2][3] Company Structure - The company is a permanent public limited company, with the chairman acting as the legal representative [2][3] - Shareholders are liable only to the extent of their subscribed shares, while the company is responsible for its debts with its total assets [2][3] - The articles of association provide a framework for the rights and obligations of shareholders, directors, and senior management [2][3] Business Objectives and Scope - The company's business objective is to maximize shareholder interests and innovate in the pharmaceutical sector [3][4] - The business scope includes the production and import/export of pharmaceuticals and hazardous chemicals, among other activities [3][4] Share Issuance and Management - The company issues shares in the form of stocks, adhering to principles of openness, fairness, and justice [4][5] - The total number of shares issued is 538,648,934, all of which are ordinary shares [4][5] - The company cannot provide financial assistance for others to acquire its shares, except under specific conditions [5][6] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, voting, and participation in company governance [9][10] - Shareholders must comply with laws and the articles of association, and they cannot withdraw their capital except as legally permitted [14][15] - The articles outline the responsibilities of controlling shareholders and actual controllers to protect the interests of the company and other shareholders [14][15] Shareholder Meetings - The company holds annual and extraordinary shareholder meetings, with specific procedures for calling and conducting these meetings [47][48] - Shareholder proposals must be submitted in advance, and the company must provide adequate notice of meetings [57][58] - The articles specify the voting procedures and requirements for decision-making during shareholder meetings [63][64]